KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EBITDA: 2019-2024

Historic EBITDA for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to -$550.3 million.

  • Ginkgo Bioworks Holdings' EBITDA fell 47.77% to -$80.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$337.8 million, marking a year-over-year increase of 47.87%. This contributed to the annual value of -$550.3 million for FY2024, which is 38.08% up from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported EBITDA of -$550.3 million as of FY2024, which was up 38.08% from -$888.8 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' EBITDA registered a high of -$137.0 million during FY2020, and its lowest value of -$2.1 billion during FY2022.
  • In the last 3 years, Ginkgo Bioworks Holdings' EBITDA had a median value of -$888.8 million in 2023 and averaged -$1.2 billion.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' EBITDA crashed by 1,241.60% in 2021 and then surged by 57.82% in 2023.
  • Ginkgo Bioworks Holdings' EBITDA (Yearly) stood at -$137.0 million in 2020, then tumbled by 1,241.60% to -$1.8 billion in 2021, then dropped by 14.63% to -$2.1 billion in 2022, then surged by 57.82% to -$888.8 million in 2023, then soared by 38.08% to -$550.3 million in 2024.